Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
批准号:
7994210
负责人:
XIAODONG CHENG
金额:
$34.39万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2013-11-30
关键词:
Abnormal CellBindingBiochemicalBiological ProcessChemotherapy-Oncologic ProcedureCollaborationsComplexCyclic AMPCyclic AMP ReceptorsCyclic AMP-Dependent Protein KinasesDataDeuteriumDevelopmentDiabetes MellitusDiagnosisDiseaseDrug Delivery SystemsDrug effect disorderEukaryotic CellGoalsGrantGuanine Nucleotide Exchange FactorsHeart failureHoloenzymesHydrogenIntracellular Second MessengerKnowledgeLeadLengthLiteratureMalignant NeoplasmsMapsMass Spectrum AnalysisMediatingMedicalModelingMolecularMolecular ConformationMotionPhysiologicalPlayPositioning AttributeProteinsPublishingRegulationResearchRoentgen RaysRoleSecond Messenger SystemsSignal PathwaySignal TransductionSite-Directed MutagenesisSolutionsStructural ModelsStructureTechniquesTestingTherapeuticTherapeutic AgentsWood materialX-Ray Crystallographybasecell growthcomparativedesignfactor Aimprovedinnovationnovelprogramspublic health relevanceresearch studythree dimensional structure
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): cAMP-mediated signaling regulates a myriad of important biological processes under physiological conditions and disease states, including diabetes, heart failure and cancer. In eukaryotic cells, the effects of cAMP are mediated by two ubiquitously expressed intracellular cAMP receptors, the classic protein kinase A/cAMP-dependent protein kinase (PKA/cAPK) and the recently discovered exchange protein directly activated by cAMP/cAMP-regulated guanine nucleotide exchange factor (Epac/cAMP-GEF). The existence of two ubiquitously expressed cAMP effectors provides a mechanism for a more precise and integrated control of the cAMP signaling pathways in a spatial and temporal manner. However, little is known about the mechanism of Epac activation. The objective of this proposal is to fill the gap in our current knowledge by mapping the conformational changes associated with Epac activation. Specifically, we have planned experiments with the following Specific Aims: 1) To determine the specific residues important for Epac activation by site-directed mutagenesis; 2) to delineate the conformational changes associated with cAMP binding and Epac activation and to determine the protein interface between Epac and its downstream effector, Rap1, using enhanced deuterium exchange-mass spectrometry (DXMS) and small-angle X-ray scattering; and 3) to solve the crystal structure of Epac2-cAMP using X-ray crystallography. The long-term goals of our research are to understand the physiological functions and mechanisms of Epac regulation. Accomplishing the proposed research in this application will significantly move the field forward towards these goals. Furthermore, the medical and pharmacological implications of this research program are also far-reaching. A better understanding of cAMP mediated signal transduction could potentially lead to the identification of novel mechanism-based therapeutic strategies specifically targeting the cAMP-signaling components.
PUBLIC HEALTH RELEVANCE: Cyclic AMP-mediated signaling regulates a myriad of important biological processes under both physiological conditions and disease states, including diabetes, heart failure and cancer. Components of the cAMP-signaling cascade have been implicated in abnormal cell growth and drug actions and successfully targeted for diagnosis and chemotherapy of cancer and other diseases. A better understanding of cAMP mediated signal transduction could potentially lead to the identification of novel drug targets and the development of new or improved therapeutic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Significance of Epac signaling in renal Na+ handling and hypertension
-
批准号:10864073
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2023
-
负责人:XIAODONG CHENG
-
依托单位:
Epac1 as a novel therapeutic target for diabetic retinopathy
-
批准号:10689112
-
项目类别:
-
资助金额:$50.62万
-
财政年份:2022
-
负责人:XIAODONG CHENG
-
依托单位:
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and Therapeutics
-
批准号:10198941
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2017
-
负责人:XIAODONG CHENG
-
依托单位:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
-
批准号:9250048
-
项目类别:
-
资助金额:$120.96万
-
财政年份:2014
-
负责人:XIAODONG CHENG
-
依托单位:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
-
批准号:9038248
-
项目类别:
-
资助金额:$125.62万
-
财政年份:2014
-
负责人:XIAODONG CHENG
-
依托单位:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
-
批准号:8694342
-
项目类别:
-
资助金额:$153.87万
-
财政年份:2014
-
负责人:XIAODONG CHENG
-
依托单位:
Novel Pharmacological Probes Targeting Exchange Proteins Activated by cAMP (EPAC)
-
批准号:8482964
-
项目类别:
-
资助金额:$49.11万
-
财政年份:2013
-
负责人:XIAODONG CHENG
-
依托单位:
High throughput assay for novel pharmacological probes targeting cAMP signaling
-
批准号:8477859
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2010
-
负责人:XIAODONG CHENG
-
依托单位:
High throughput assay for novel pharmacological probes targeting cAMP signaling
-
批准号:7991500
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2010
-
负责人:XIAODONG CHENG
-
依托单位:
Genetic Screening:Oncogene RAS-Based Inhibi*(RMI)
-
批准号:7058055
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2005
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:6743684
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:6888183
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:9260012
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7238664
-
项目类别:
-
资助金额:$25.71万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8762253
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7583771
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8783945
-
项目类别:
-
资助金额:$23.42万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8387786
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:8197449
-
项目类别:
-
资助金额:$34.46万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor
-
批准号:7059367
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2003
-
负责人:XIAODONG CHENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: